Maccura Biotechnology (300463.SZ) plans to repurchase company shares worth between 50 million to 100 million yuan.
Mike Biology (300463.SZ) announced that the company plans to use its own funds to repurchase some of the company's issued Renminbi ordinary shares (A shares) through centralized bidding trading, in order to cancel and reduce the registered capital. The fund for repurchasing shares shall not be less than 50 million yuan and shall not exceed 100 million yuan (both inclusive), and the repurchase price shall not exceed 14.66 yuan per share (inclusive).
Maccura Biotechnology (300463.SZ) announced that the company plans to use its own funds to repurchase some of the company's issued Renminbi ordinary shares (A shares) in a centralized bidding trading manner, for the purpose of cancellation and reduction of registered capital. The amount of funds for repurchasing shares shall not be less than 50 million yuan and not more than 100 million yuan (including the amount). The repurchase price of shares shall not exceed 14.66 yuan per share (including).
Related Articles
China Securities Co., Ltd.: After a short-term rebound, A shares may fluctuate. AI computing power remains the main trend in the medium to long term.
AMASSE CAPITAL (08168): Shareholders demand the removal of current directors.
CITIC SEC: Rate hikes difficult to shake AI valuation, non-AI weakness needs to break through its own narrative.
China Securities Co., Ltd.: After a short-term rebound, A shares may fluctuate. AI computing power remains the main trend in the medium to long term.
AMASSE CAPITAL (08168): Shareholders demand the removal of current directors.
CITIC SEC: Rate hikes difficult to shake AI valuation, non-AI weakness needs to break through its own narrative.
RECOMMEND
